Diuzid

Quick links to important sections

Diuzid

Method of action: Diuretic

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Diuzid

Property Description
Active Ingredient Hydrochlorothiazide (HCTZ)
Form Oral Tablet or Capsule
Pharmacological Class Thiazide Diuretic, Antihypertensive
Common Use Managing high blood pressure and fluid retention
Origin Synthetic Compound (Sulfonamide-derived)

Defining Diuzid: Active Ingredient and Pharmacological Type

Diuzid is a pharmaceutical preparation whose active ingredient is Hydrochlorothiazide (HCTZ), a synthetic compound used for oral administration. The medication is formally classified as a thiazide-type diuretic and an established antihypertensive agent, belonging chemically to the sulfonamide-derived drug group. This classification defines its fundamental function as influencing the body's fluid and salt balance. Hydrochlorothiazide is included on the World Health Organization's Model List of Essential Medicines due to its established efficacy in the healthcare system.

General Purpose of the Thiazide Diuretic Class

The core purpose of this class of medication is the control of volume-related conditions, primarily managing hypertension (high blood pressure) and addressing edema (fluid retention). The drug’s utility is clinically recognized for promoting the necessary reduction of systemic fluid volume. This effect is crucial for achieving sustained, long-term control over high blood pressure, and it is frequently used to provide relief from symptomatic fluid accumulation associated with conditions like congestive heart failure. Its differentiating mechanism sets it apart from diuretics that act on other parts of the nephron.

How Hydrochlorothiazide Relates to Fluid Balance

The general action of Hydrochlorothiazide involves promoting diuresis, which is the increased excretion of water, achieved through natriuresis, the increased excretion of sodium. It acts within the kidneys to prevent the normal reabsorption of sodium and chloride ions back into the blood, causing them to be excreted with water. The resulting removal of excess salt and water is the conceptual basis for how Hydrochlorothiazide reduces the total fluid volume, thus lowering overall pressure within the arteries.

Regulatory References

  1. World Health Organization's Model List of Essential Medicines

What side effects are possible with Diuzid?

Diuzid (Hydrochlorothiazide) is a sulfonamide-derived medicine, and its safety profile is formally documented by regulatory authorities, with adverse reactions classified by affected body system and frequency.

Officially Documented Adverse Reactions

The most frequent adverse reactions are generally classified under Metabolism and Nutrition Disorders. Common effects include hypokalemia (low potassium levels), hyperglycemia (high blood sugar), and hyperuricemia (elevated uric acid), which may lead to gout.

Reactions affecting the Vascular System often involve volume changes, with orthostatic hypotension (dizziness upon standing) listed as an uncommon effect. Uncommon effects in the Skin and Subcutaneous Tissue include photosensitivity reactions.

Serious Adverse Reactions and Safety Constraints

Specific rare but serious adverse reactions are highlighted in regulatory labeling. These include the potential for acute angle-closure glaucoma, an ocular emergency often reported early in treatment. Rare effects on the Blood and Lymphatic System include conditions like thrombocytopenia and agranulocytosis. Furthermore, an increased risk of Non-Melanoma Skin Cancer (NMSC) is associated with the drug's long-term, cumulative use.

Safety documents define specific Contraindications where the medicine must not be used. These include known hypersensitivity to sulfonamide-derived drugs and the presence of anuria or severe renal impairment.

Overdose and Emergency Response

Overdose and when to seek help

Overdosage with Diuzid (Hydrochlorothiazide) is officially documented by regulatory authorities to result from excessive fluid and electrolyte loss. The primary clinical manifestations stem from this depletion, typically including signs of dehydration, hypotension (low blood pressure), tachycardia (increased heart rate), drowsiness, confusion, and gastrointestinal upset such as nausea and vomiting.

Severe and life-threatening outcomes are associated with profound imbalances. These may include major cardiac arrhythmias and significant central nervous system effects such as seizures or coma (unresponsiveness). In patients with underlying renal or hepatic impairment, overdosage carries the specific regulatory-documented risk of developing acute renal failure or precipitating hepatic coma.

Required Emergency Actions

Regulatory information mandates that individuals seek immediate medical attention or contact Poison Control when an overdosage is suspected. Urgent medical intervention is required, especially if symptoms escalate to trouble breathing, seizures, or loss of consciousness. There is no specific antidote documented in the official labeling. Management is strictly symptomatic and supportive, often requiring hospitalization for the administration of intravenous fluids to correct volume and electrolyte loss, and continuous monitoring of vital signs, renal function, and cardiac function via ECG.

Therapeutic Uses of Diuzid

What Diuzid Treats: Main Uses and Benefits

Diuzid, which contains hydrochlorothiazide, is a diuretic medication prescribed to help manage conditions linked to excessive fluid retention and elevated blood pressure. Its purpose is to provide therapeutic assistance for conditions involving fluid retention.

The core uses of Diuzid are indicated for treating hypertension (high blood pressure) and various forms of edema (swelling or fluid retention). The medication is used to control high blood pressure, which is a key part of managing cardiovascular health.

In clinical scenarios, the medication is commonly used to address swelling associated with conditions such as congestive heart failure, liver cirrhosis, and certain kidney disorders. This action may contribute to symptom relief by supporting the reduction of excess fluid.

“Management of fluid volume is an important part of supporting several chronic conditions, including heart failure.”


Quick Fact: Fluid Management Support The medication helps address excess fluid, which is associated with symptoms like swelling in the legs, ankles, and feet.


It may also be prescribed for secondary uses, such as to support the management of certain factors related to kidney stones in some patients, when advised by a healthcare provider.

Eligibility and Restrictions for Use

Who Can and Cannot Use Diuzid?

The use of Diuzid (Hydrochlorothiazide) is strictly governed by population eligibility rules defined in official regulatory documents.


Absolute Contraindications

Diuzid is strictly contraindicated and must not be used by patients with anuria (inability to produce urine) or a known hypersensitivity to sulfonamide-derived drugs. Use is also prohibited in cases of severe hepatic impairment (including biliary cirrhosis and cholestasis), as well as pre-existing, refractory hypokalaemia or hypercalcaemia.


Restricted Populations and Conditional Use

Official labeling defines several populations requiring restriction or caution:

  • Pregnancy and Lactation: Use is contraindicated during the second and third trimesters of pregnancy. Use during the first trimester is permitted only if clearly needed. The medicine is not recommended for nursing mothers.
  • Organ Function: Diuzid is not recommended for patients with severe renal impairment (typically Creatinine Clearance < 30 mL/min). Caution is required for those with non-severe progressive liver disease.
  • Comorbidities: Caution is necessary for patients with Systemic Lupus Erythematosus (SLE), gout or hyperuricemia, and diabetes mellitus.
  • Age: The safety and effectiveness of Diuzid in pediatric patients (under 18) have not been established.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Hydrochlorothiazide (HCTZ), the active component of Diuzid, has formally documented interaction patterns that can modify the exposure or effect of co-administered substances. Regulatory agencies classify certain combinations as restricted or contraindicated. The co-administration of Diuzid with Lithium is generally not recommended because the diuretic reduces the renal clearance of Lithium, leading to a high risk of toxicity. The combination with Aliskiren is contraindicated in patients with existing diabetes or moderate-to-severe renal impairment.

Documented Pharmacodynamic and Exposure Interactions

Interactions affecting drug exposure include those with Cholestyramine and Colestipol resins, which impair the absorption of HCTZ. To manage this effect, official regulatory documents specify that Diuzid must be administered at least one hour before or 4–6 hours after these resins.

Pharmacodynamic interactions can lead to an additive effect with other antihypertensive drugs or potentiation of orthostatic hypotension when taken with substances like alcohol or barbiturates. Conversely, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) may reduce Diuzid's natriuretic and antihypertensive effects. Co-administration with Corticosteroids or ACTH intensifies the risk of hypokalemia (low potassium). Patients taking antidiabetic drugs may require a dosage adjustment due to the documented effect on glucose metabolism. Caution is also documented for use in patients with impaired hepatic function due to the risk of precipitating hepatic coma.

Mechanism of Action

Diuzid (hydrochlorothiazide) is a thiazide-type diuretic that exerts its effects by acting on the renal distal convoluted tubule (DCT). Its primary molecular target is the sodium-chloride cotransporter (NCC), also known as solute carrier family 12 member 3 (SLC12A3), located on the apical membrane of the DCT epithelial cells.

Diuzid functions as an inhibitor of the NCC, blocking the active transport of both sodium ( Na^+) and chloride ( Cl^-) ions from the tubular lumen into the cell. This inhibition reduces the reabsorption of these ions from the filtrate. The resultant increase in the concentration of Na^+ and Cl^- in the tubular fluid generates an osmotic gradient, which in turn leads to a decrease in water ( H2 O) reabsorption from the renal tubule, ultimately increasing the volume of the excreted fluid (diuresis). This natriuretic and diuretic cascade results in a system-level physiological consequence of decreased extracellular fluid and plasma volume.

Dosage and Administration Information

How to Use Diuzid — Official Administration Guidelines

Diuzid (Amiloride Hydrochloride/Hydrochlorothiazide) is an oral medication that must be used strictly according to the prescribing information.

Administration and Dosing

Guideline Official Instruction
Route of Administration Oral (by mouth)
Dosing Schedule (Adults) Typically taken once daily as a single dose.
Timing in Relation to Meals May be administered with or without food.
Preferred Time of Day Should be taken in the morning.
Adult Dosing Range The dose may be adjusted, commonly ranging from 5 mg/50 mg to 10 mg/100 mg (Amiloride/Hydrochlorothiazide) once daily or in divided doses. Doses exceeding Amiloride 10 mg/Hydrochlorothiazide 100 mg per day are generally not needed.
Pediatric Dosing Dosing is weight-based (1 to 2 mg/kg per day) and given in one or two divided doses, with specific maximum daily limits based on age.

Procedural and Missed Dose Instructions

  • Morning Administration: The medicine is typically taken in the morning to prevent the diuretic effect from interfering with sleep.
  • Intermittent Therapy: For the treatment of edema, administration may be scheduled intermittently, such as on alternate days or for three to five days each week, to reduce the risk of electrolyte imbalances.
  • Missed Dose: If a dose is missed, take it as soon as you remember. If it is almost time for the next scheduled dose, skip the missed dose and return to the regular dosing schedule. Do not double the dose.

These instructions establish the oral, once-daily regimen, including the maximum dose limits and specific timing, which define the standardized procedural structure for using this medicine.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Efficacy and Area of Investigation

Research has been conducted on Diuzid (a fixed-dose combination of a thiazide diuretic and a potassium-sparing diuretic) for primary hypertension and edema. The primary area of research involves whether the compound interacts with specific biological pathways to affect fluid and electrolyte balance, which has been a long-standing area of investigation for this drug class.


Clinical Trial Findings

Study 1: Blood Pressure Evaluation

A double-blind, randomized controlled trial evaluated the effect of different dosing regimens of the components of Diuzid on measurable blood pressure endpoints. Key outcome measures included changes in office and ambulatory systolic and diastolic blood pressure (BP).

Comparative research examined data between Diuzid and other compounds to gather evidence on BP reduction. Findings across multiple studies show that combination therapies often provide greater BP-lowering efficacy than monotherapy, particularly for patients with higher baseline BP levels.

Study 2: Long-Term Tolerance

Studies focused on long-term usage have tracked participants over several years to assess sustained use. The studies collected data on participant tolerance over these durations, noting the occurrence of common events such as metabolic changes (e.g., in blood glucose and potassium levels).

Comparison to Other Diuretics

Comparative research has also examined data related to the efficacy and duration of action when thiazide diuretics are used alone versus in combination with a potassium-sparing agent, with study protocols including specific guidance regarding administration. The aim of these studies is to contribute to the overall body of evidence regarding the properties of Diuzid for the management of fluid-related conditions and hypertension.

Frequently Asked Questions (FAQ)

Common questions about Diuzid (FAQ)

Q: What is the main reason Diuzid is prescribed by doctors?

A: Diuzid is officially indicated for treating high blood pressure (hypertension) and fluid retention (edema) in patients, according to regulatory documents. It is often used in people who have experienced low potassium levels (hypokalemia) while using other types of diuretics.

Q: Why do some people refer to Diuzid as a 'water pill'?

A: The medicine is a type of diuretic, which is commonly known as a 'water pill' in patient education materials. Official information explains that it works by increasing the flow and volume of urine to help the body eliminate excess fluid, which addresses fluid retention.

Q: How quickly can a person expect to notice any effects from Diuzid?

A: Pharmacology information states that the diuretic effect of both components in Diuzid typically begins within two hours after taking an oral dose. The full effect on the body’s electrolyte balance generally reaches its peak between four and ten hours, depending on the specific component.

Q: Is it normal to feel a bit light-headed when first starting Diuzid?

A: Dizziness and lightheadedness are listed in regulatory documents as possible adverse reactions. The official safety information notes that these feelings may be worse if the body loses too much water, such as through heavy sweating, vomiting, or diarrhea. Regulatory safety information suggests caution regarding alertness, especially when driving or operating machinery.

Q: What is the typical duration of treatment with Diuzid?

A: According to patient information regarding hypertension, the condition may require medicine for the rest of a person's life. The length of time Diuzid is taken is determined by the healthcare provider based on the medical condition and the patient’s clinical course.

Q: What are the most commonly reported side effects of Diuzid?

A: Official regulatory documentation reports that the most common adverse reactions include general feelings of weakness or tiredness, headache, dizziness, nausea, and skin rash. A full list of possible side effects is available in the official prescribing information.

Q: Will taking Diuzid affect my ability to drive or operate machinery?

A: Regulatory safety information advises that activities requiring full alertness, such as driving or operating machinery, should be avoided until an individual knows how the medicine affects them. This is because the drug may cause dizziness or drowsiness.

Q: Can women who are planning pregnancy use Diuzid?

A: Official regulatory classification of this medicine during pregnancy is Category C. This means that studies have shown or suggest the drug may cause harmful effects on the fetus or newborn. The medication is advised to be used during pregnancy only if a healthcare provider determines it is clearly necessary.

Q: What kind of scientific evidence supports the use of Diuzid?

A: The use of Diuzid is supported by clinical data that led to its official approval and indications from regulatory agencies. These indications confirm its role in treating high blood pressure and fluid retention associated with congestive heart failure in certain patients.

Q: Is Diuzid known to interact with herbal supplements?

A: While specific herbal products may not be listed, general patient information advises informing a healthcare provider about all medicines, including vitamins and herbal supplements. This step helps the healthcare provider assess the potential for interactions and manage the overall safety of the medication regimen.

Q: What should be done if someone experiences severe muscle cramps while taking Diuzid?

A: Severe muscle cramps are listed in official documents as a symptom potentially associated with an electrolyte imbalance, such as a drop in sodium or potassium levels. In official patient literature, individuals are advised to contact a healthcare provider promptly if severe symptoms such as muscle cramps occur.

Q: Can Diuzid be used by people with a history of gout?

A: Regulatory warnings advise caution for use in individuals with a history of gout. The hydrochlorothiazide component may elevate uric acid levels in the blood, which could precipitate gout (cause a gout flare) in susceptible patients.

Q: What are the restrictions for people with diabetes considering Diuzid?

A: Official warnings suggest that Diuzid should generally be avoided in patients with diabetes mellitus. This is due to the potential risk of hyperkalemia (high potassium) and the possibility that the medicine could affect blood sugar control.

Q: What effect does Diuzid have on cholesterol levels?

A: Studies noted in regulatory documents indicate that the hydrochlorothiazide component, a thiazide diuretic, may increase serum levels of both triglycerides and cholesterol. These changes may or may not continue throughout the entire course of long-term therapy.

Q: Does Diuzid have any warnings regarding severe liver impairment?

A: Yes, regulatory safety information advises caution in patients with severe hepatic dysfunction (impaired liver function). This is because electrolyte imbalances caused by the diuretic might lead to a serious complication known as hepatic encephalopathy or coma.

Q: Are there any specific foods or drinks that should be avoided while using Diuzid?

A: Official information indicates that people taking this medicine should generally avoid using potassium supplements, potassium-containing salt substitutes, or diets very rich in potassium. This is because the medication is designed to conserve potassium, and adding extra potassium may cause an unsafe increase in those levels.

Q: Does official prescribing information warn about sun sensitivity while using Diuzid?

A: Yes, official warnings note that the hydrochlorothiazide component can cause photosensitivity (increased sensitivity to light) and may increase the risk of non-melanoma skin cancer. It is advised to protect oneself from sun exposure, sunlamps, and tanning beds while using this medicine.

Q: How does Diuzid affect the body's mineral or electrolyte balance?

A: The medicine works in the kidneys to affect the reabsorption of minerals. It increases the excretion of sodium and chloride while the amiloride component works to help conserve potassium. Regulatory documents note that the drug still carries a risk of imbalances, including low sodium (hyponatremia) or high potassium (hyperkalemia).

Q: Why do doctors check potassium levels when prescribing Diuzid?

A: Regulatory documents state that careful monitoring of serum potassium levels is essential, especially when the drug is started or the dose is changed. This is because the medicine can cause a potentially unsafe increase in potassium levels (hyperkalemia).

Q: Does Diuzid cause weight changes, and if so, how?

A: As a diuretic, the medicine's primary effect is to increase urine production, which leads to fluid loss. Patient information lists this fluid loss, which is the mechanism of action, as a potential cause of weight loss.

Q: Can children or adolescents use Diuzid?

A: Regulatory information includes weight-based pediatric dosing guidelines for the components of Diuzid. However, some prescribing information notes that the combination drug may not be generally recommended for use in children, and use is determined by a specialist.

Q: Is Diuzid a controlled substance or scheduled drug?

A: According to regulatory resources in the United States, Diuzid is not listed as a controlled substance or scheduled drug by the DEA (Drug Enforcement Administration).

How should Diuzid be stored and disposed of?

How to Store and Dispose of Diuzid?

Diuzid (hydrochlorothiazide) must be stored and handled according to specific regulatory requirements to maintain its stability and ensure household safety.

Storage Requirements

The product must be stored at Controlled Room Temperature, defined as 20 C to 25 C (68 F to 77 F), with protection from temperature excursions. Regulatory labeling explicitly requires the product to be protected from light, moisture, and freezing. To maintain integrity, the medicine must be kept in its tightly closed, original container.

Safety and Disposal

All medication must be stored out of the reach and sight of children. Unused or expired Diuzid should be discarded using an authorized drug take-back program. If a program is unavailable, the FDA recommends mixing the medicine with an undesirable substance (such as used coffee grounds or dirt), sealing it in a container, and disposing of it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Diuzid found in:

A-Z Index: